Critics highlight that the cost-cutting proposals fall short of President Trump’s campaign pledge to make IVF free.
It was a major talking point in the final months of Donald Trump’s 2024 presidential campaign: If re-elected, the Republican leader pledged to make in vitro fertilisation (IVF) free for those seeking to get pregnant.
“Under the Trump administration, we are going to be paying for that treatment,” Trump told NBC News last year, adding that his plans would cover “all Americans that get it, all Americans that need it”.
“We’re going to be paying for that treatment. Or we’re going to be mandating that the insurance company pay.”
While that campaign promise remains unrealised, the Trump administration took a step on Thursday to make the procedure more accessible.
Speaking from the Oval Office, Trump announced a collaboration with the company EMD Serono, a subsidiary of the pharmaceutical giant Merck, to offer lower-priced fertility drugs on his upcoming prescription marketplace, TrumpRx.
“ EMD Serono, the largest fertility drug manufacturer in the world, has agreed to provide massive discounts to all fertility drugs they sell in the United States, including the most popular drug of all, the IVF drug Gonal-F,” Trump told
Continue Reading on Al Jazeera
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.